Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Peripheral × VAP-cyclo protocol × Clear all

NCT05963347 2023-09-01

Go-CHOP as the Frontline Therapy for PTCL

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral